Syngene International's Q1 FY 2026-27 Quarterly Results

Result Summary

• Syngene International Ltd reported a 28.1% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Jun (Q1 FY 2026-27). On a year-on-year (YoY) basis, it witnessed a decline of 14.7%.
• Its expenses for the quarter were down by 10.5% QoQ and 3.0% YoY.
• The net profit decreased 106.1% QoQ and decreased 110.4% YoY.
• The earnings per share (EPS) of Syngene International Ltd declined at 0.22 during Q1 FY 2026-27.

Financial Statments for Q1 FY 2026-27

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Syngene International Ltd is a leading contract research and manufacturing services (CRAMS) company, specializing in providing comprehensive research, development, and manufacturing services to pharmaceutical, biotechnology, and other industries worldwide. The company operates within the life sciences sector, offering services such as discovery chemistry, biology, safety assessment, and large-scale manufacturing. Syngene is known for its state-of-the-art infrastructure and skilled workforce, which enables it to cater to a global clientele. Recent developments regarding the company or industry trends are not available in the provided data.

Revenue

In the first quarter of FY27, Syngene International Ltd reported a total income of ₹761.30 crores, exhibiting a decrease from the previous quarter's total income of ₹1,058.70 crores. This represents a quarter-over-quarter (QoQ) decline of 28.1%. Compared to the same period in the previous financial year (Q1FY26), the total income decreased from ₹892.20 crores, marking a year-over-year (YoY) reduction of 14.7%. The company experienced a significant downward trend in revenue generation during this period.

Profitability

Syngene International Ltd's profitability in Q1FY27 witnessed a notable downturn. The company recorded a loss before tax of ₹19.20 crores, a sharp decline from the profit before tax of ₹196.00 crores in Q4FY26. The QoQ change thus stands at -109.8%. When compared to Q1FY26, where the profit before tax was ₹101.30 crores, the YoY change is -119.0%. The tax expense for Q1FY27 was a negative ₹10.20 crores, compared to ₹48.10 crores in Q4FY26 and ₹14.60 crores in Q1FY26, reflecting significant reductions both QoQ and YoY. Consequently, the profit after tax also fell to a negative ₹9.00 crores from ₹147.90 crores in Q4FY26 and ₹86.70 crores in Q1FY26, showing a QoQ change of -106.1% and a YoY change of -110.4%.

Operating Metrics

Earnings per share (EPS) for Syngene International Ltd in Q1FY27 were reported at a negative ₹0.22, compared to ₹3.67 in Q4FY26 and ₹2.15 in Q1FY26, indicating a significant decline QoQ by 106.0% and YoY by 110.2%. Total expenses for the quarter were ₹767.00 crores, which decreased from ₹856.70 crores in the previous quarter, resulting in a QoQ change of -10.5%. Compared to Q1FY26, where total expenses were ₹790.90 crores, there was a YoY decrease of 3.0%. The financial data indicates considerable fluctuations in the company's operating metrics, reflecting the overall financial performance for the quarter.